Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Theodoros Evrenoglou"'
Publikováno v:
BMC Medical Research Methodology, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background Preprints are increasingly used to disseminate research results, providing multiple sources of information for the same study. We assessed the consistency in effect estimates between preprint and subsequent journal article of COVI
Externí odkaz:
https://doaj.org/article/367635dda20d4be1922c753084e4be5f
Publikováno v:
Research Synthesis Methods. 14:479-488
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::590ad1e62c396e51ccc3df20f52cfadc
https://doi.org/10.1002/jrsm.1627
https://doi.org/10.1002/jrsm.1627
Autor:
Mauricia Davidson, Sonia Menon, Anna Chaimani, Theodoros Evrenoglou, Lina Ghosn, Carolina Graña, Nicholas Henschke, Elise Cogo, Gemma Villanueva, Gabriel Ferrand, Carolina Riveros, Hillary Bonnet, Philipp Kapp, Conor Moran, Declan Devane, Joerg J Meerpohl, Gabriel Rada, Asbjørn Hróbjartsson, Giacomo Grasselli, David Tovey, Philippe Ravaud, Isabelle Boutron
Publikováno v:
Cochrane Database Syst Rev
Davidson, M, Menon, S, Chaimani, A, Evrenoglou, T, Ghosn, L, Graña, C, Henschke, N, Cogo, E, Villanueva, G, Ferrand, G, Riveros, C, Bonnet, H, Kapp, P, Moran, C, Devane, D, Meerpohl, J J, Rada, G, Hróbjartsson, A, Grasselli, G, Tovey, D, Ravaud, P & Boutron, I 2022, ' Interleukin-1 blocking agents for treating COVID-19 ', Cochrane Database of Systematic Reviews, vol. 2022, no. 1, CD015308 . https://doi.org/10.1002/14651858.CD015308
Davidson, M, Menon, S, Chaimani, A, Evrenoglou, T, Ghosn, L, Graña, C, Henschke, N, Cogo, E, Villanueva, G, Ferrand, G, Riveros, C, Bonnet, H, Kapp, P, Moran, C, Devane, D, Meerpohl, J J, Rada, G, Hróbjartsson, A, Grasselli, G, Tovey, D, Ravaud, P & Boutron, I 2022, ' Interleukin-1 blocking agents for treating COVID-19 ', Cochrane Database of Systematic Reviews, vol. 2022, no. 1, CD015308 . https://doi.org/10.1002/14651858.CD015308
Background: Interleukin-1 (IL-1) blocking agents have been used for treating severe coronavirus disease 2019 (COVID-19), on the premise that their immunomodulatory effect might be beneficial in people with COVID-19. Objectives: To assess the effects
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d15aeff598e543382e90a01ed2fd834f
https://pubmed.ncbi.nlm.nih.gov/35080773
https://pubmed.ncbi.nlm.nih.gov/35080773
Autor:
Carolina Graña, Lina Ghosn, Theodoros Evrenoglou, Alexander Jarde, Silvia Minozzi, Hanna Bergman, Brian S Buckley, Katrin Probyn, Gemma Villanueva, Nicholas Henschke, Hillary Bonnet, Rouba Assi, Sonia Menon, Melanie Marti, Declan Devane, Patrick Mallon, Jean-Daniel Lelievre, Lisa M Askie, Tamara Kredo, Gabriel Ferrand, Mauricia Davidson, Carolina Riveros, David Tovey, Joerg J Meerpohl, Giacomo Grasselli, Gabriel Rada, Asbjørn Hróbjartsson, Philippe Ravaud, Anna Chaimani, Isabelle Boutron
Publikováno v:
Cochrane Database of Systematic Reviews. 2023
Different forms of vaccines have been developed to prevent the SARS-CoV-2 virus and subsequent COVID-19 disease. Several are in widespread use globally. OBJECTIVES: To assess the efficacy and safety of COVID-19 vaccines (as a full primary vaccination
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a5f91b03c5a4fb8c436a320f1e20357
https://doi.org/10.1002/14651858.cd015477
https://doi.org/10.1002/14651858.cd015477
Publikováno v:
Statistics in Medicine
Statistics in Medicine, 2022, 41 (26), pp.5203-5219. ⟨10.1002/sim.9562⟩
Statistics in Medicine, 2022, 41 (26), pp.5203-5219. ⟨10.1002/sim.9562⟩
Network meta-analysis (NMA) of rare events has attracted little attention in the literature. Until recently, networks of interventions with rare events were analyzed using the inverse-variance NMA approach. However, when events are rare the normal ap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1098c4490700b7d3078ea6194a5b888
https://pubmed.ncbi.nlm.nih.gov/36054668
https://pubmed.ncbi.nlm.nih.gov/36054668
Publikováno v:
Journal of Clinical Epidemiology
Journal of Clinical Epidemiology, Elsevier, 2021, 133, pp.72-79. ⟨10.1016/j.jclinepi.2021.01.013⟩
Journal of Clinical Epidemiology, 2021, 133, pp.72-79. ⟨10.1016/j.jclinepi.2021.01.013⟩
Journal of Clinical Epidemiology, Elsevier, 2021, 133, pp.72-79. ⟨10.1016/j.jclinepi.2021.01.013⟩
Journal of Clinical Epidemiology, 2021, 133, pp.72-79. ⟨10.1016/j.jclinepi.2021.01.013⟩
International audience; Background: The availability of effective treatments for psoriasis raises ethical questions about the use of a placebo group in therapeutic trials. We evaluated the use of the placebo over time in such trials.Methods: From tri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::583eeb90dce4108b7ff3fbf7da1a0e61
https://doi.org/10.1016/j.jclinepi.2021.01.013
https://doi.org/10.1016/j.jclinepi.2021.01.013
Autor:
Theodoros Evrenoglou
Publikováno v:
British Journal of Dermatology. 187:637-638
Linked article: Mavranezouli et al. Br J Dermatol 2022; 187:639–649.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd6acb3ca8d344d1a3b4a24b8957b408
https://doi.org/10.1111/bjd.21849
https://doi.org/10.1111/bjd.21849
“Living” evidence synthesis is of primary interest for decision-makers to overcome the COVID-19 pandemic. The COVID-NMA provides open-access living meta-analyses assessing different therapeutic and preventive interventions. Data are posted on a p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8bfa14a632898dc8598e5ddb547169dc
https://doi.org/10.1101/2021.09.07.21263207
https://doi.org/10.1101/2021.09.07.21263207
Autor:
Anna Chaimani, Philippe Ravaud, Camilla Hansen Nejstgaard, Declan Devane, Isabelle Boutron, Lina Ghosn, Sonia Menon, David Tovey, Claudia Bollig, Gabriel Rada, Gabriel Ferrand, Yanina Sguassero, Christine Schmucker, Mauricia Davidson, Joerg J Meerpohl, Carolina Graña, Carolina Riveros, Philipp Kapp, Theodoros Evrenoglou, Camila Ávila, Thu Van Nguyen, Nicholas Henschke, Giacomo Grasselli, Asbjørn Hróbjartsson
Publikováno v:
Ghosn, L, Chaimani, A, Evrenoglou, T, Davidson, M, Graña, C, Schmucker, C, Bollig, C, Henschke, N, Sguassero, Y, Nejstgaard, C H, Menon, S, Nguyen, T V, Ferrand, G, Kapp, P, Riveros, C, Ávila, C, Devane, D, Meerpohl, J J, Rada, G, Hróbjartsson, A, Grasselli, G, Tovey, D, Ravaud, P & Boutron, I 2021, ' Interleukin-6 blocking agents for treating COVID-19 : a living systematic review ', Cochrane Database of Systematic Reviews, vol. 2021, no. 3, CD013881 . https://doi.org/10.1002/14651858.CD013881
Background: Interleukin 6 (IL-6) blocking agents have been used for treating severe coronavirus disease 2019 (COVID-19). Their immunosuppressive effect might be valuable in patients with COVID-19 characterised by substantial immune system dysfunction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d9824f70ca70950b4a81b083a6e39d2
https://pubmed.ncbi.nlm.nih.gov/34058104
https://pubmed.ncbi.nlm.nih.gov/34058104